Commentary from IHI faculty member Kirsten Meisinger is included in this Modern Healthcare article on team-based care.
This article includes a video interview with Barbara Balik on addressing burnout and finding joy in work.
This article includes new research on end-of-life care from the Massachusetts Coalition for Serious Illness Care and includes commentary from Maureen Bisognano, co-chair of the Coalition .
The glass particles could block the actuator and impact the functionality of the pump and expose patients to the glass particles.
This article discusses one hospital's success in reducing hospital aquired infections with the help of using IHI's methodologies and programs.
Allergan recently identified, through a physician report, that four placebo capsules were placed out of order in a sample pack of TAYTULLA. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules. As a result of this packaging error, oral contraceptive capsules, that are taken out of sequence, may place the user at risk for contraceptive failure and unintended pregnancy. The reversing of the order may not be apparent to either new users or previous users of the product, increasing the likelihood of taking the capsules out of order. If patients have concerns regarding the possibility of an unintended pregnancy they should consult their physician.
Six ways for health care staff to help counteract negative emotions of cancer patients are offered in this article, which may improve outcomes in cancer care.
The products may be contaminated with bacteria. Topical administration of the products could result in potentially serious bacterial infections in immunocompromised individuals.
This article contains an interview with Barbara Balik that centers on the main causes of burnout.
IHI’s Forum is highlighted in this blog post by a physician who attended the event.
This article includes comments from Don Berwick on how the NHS could benefit from a parternship from all local health and care organizations.
This article announces the #QiComms Charter launched at the 2018 International Forum on Quality and Safety in Healthcare in Amsterdam and includes the seven principles of the charter.
Methanol,a highly toxic type of alcohol, can cause serious and sometimes fatal damage if ingested by humans or animals.
Oral over-the-counter benzocaine products should not be used to treat infants and children younger than 2 years and should only be used in adults and children 2 years and older if they contain certain warnings on the drug label.
The class I recall is due to a malfunction in the device’s outflow graft assembly that may cause the outflow graft to twist and close up (occlusion) over time. Occlusion of the outflow graft can reduce or stop pump flow and set off a persistent low flow alarm in the system. A reduction in pump can lead to serious adverse events such as blood clots and death.
Representatives of prominent national organizations and agencies to begin work on developing a national action plan for patient safety.
Manufacturing products without proper process controls increases the probability that products will vary in strength, quality and purity
Preliminary results from an ongoing observational study in Botswana found that women who received dolutegravir at the time of becoming pregnant or early in the first trimester appear to be at higher risk for these defects. Neural tube defects are birth defects that can occur early in pregnancy when the spinal cord, brain, and related structures do not form properly. To date, in this observational study there are no reported cases of babies born with neural tube defects to women starting dolutegravir later in pregnancy. We are investigating this new safety issue and will update the public when we have more information.
May 17, 2018 | Patients and families are playing a greater role in health care quality improvement. Now, some organizations believe it's essential for patients and families to have training in basic improvement to enhance their influence and involvement.
Early reviews found patients in the monotherapy arms of both trials with PD-L1 low status had decreased survival compared to patients who received cisplatin- or carboplatin-based chemotherapy.